Comparison of Recombinant MVA Selection Methods Based on F13L, D4R and K1L Genes
Modified vaccinia Ankara (MVA) is a promising vaccine vector due to its highly attenuated phenotype and good immunogenicity. However, obtaining a new recombinant MVA remains a tedious and laborious procedure involving many rounds of plaque purification. Recombinant MVA generation can be greatly impr...
Main Authors: | Irina V. Antoshkina, Dina V. Glazkova, Felix A. Urusov, Elena V. Bogoslovskaya, German A. Shipulin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/14/3/528 |
Similar Items
-
Development of MVA-d34 Tetravalent Dengue Vaccine: Design and Immunogenicity
by: Ramil R. Mintaev, et al.
Published: (2023-04-01) -
Development of a Universal Epitope-Based Influenza Vaccine and Evaluation of Its Effectiveness in Mice
by: Ramil R. Mintaev, et al.
Published: (2022-03-01) -
Time- and cost-effective production of untagged recombinant MVA by flow virometry and direct virus sorting
by: Daniela Boselli, et al.
Published: (2023-07-01) -
Preclinical evaluation of a recombinant MVA expressing the hemagglutinin-neuraminidase envelope protein of parainfluenza virus 5 (Mammalian orthorubulavirus 5)
by: D.S.O. Daian e Silva, et al.
Published: (2023-06-01) -
Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus
by: Juan García-Arriaza, et al.
Published: (2021-08-01)